Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7522233rdf:typepubmed:Citationlld:pubmed
pubmed-article:7522233lifeskim:mentionsumls-concept:C0021758lld:lifeskim
pubmed-article:7522233lifeskim:mentionsumls-concept:C0079784lld:lifeskim
pubmed-article:7522233lifeskim:mentionsumls-concept:C0018183lld:lifeskim
pubmed-article:7522233lifeskim:mentionsumls-concept:C0021764lld:lifeskim
pubmed-article:7522233lifeskim:mentionsumls-concept:C0031621lld:lifeskim
pubmed-article:7522233lifeskim:mentionsumls-concept:C0656342lld:lifeskim
pubmed-article:7522233lifeskim:mentionsumls-concept:C1519726lld:lifeskim
pubmed-article:7522233lifeskim:mentionsumls-concept:C1333707lld:lifeskim
pubmed-article:7522233lifeskim:mentionsumls-concept:C0004083lld:lifeskim
pubmed-article:7522233lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:7522233lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:7522233pubmed:issue38lld:pubmed
pubmed-article:7522233pubmed:dateCreated1994-10-20lld:pubmed
pubmed-article:7522233pubmed:abstractTextBinding of interleukin (IL)-3 and granulocyte/macrophage colony-stimulating factor (GM-CSF) to their high affinity cell surface receptors induces tyrosine phosphorylation of a similar set of protein substrates. We have identified one of these common substrates (p70) as the protein-tyrosine phosphatase SHPTP2. The Src homology 2 (SH2) domain of the adaptor protein Grb2 bound with high affinity to tyrosine-phosphorylated SHPTP2 following treatment of cells with IL-3 or GM-CSF, but not IL-4. This interaction was inhibited by two phosphotyrosine peptides, based on sequences within SHPTP2, which conform to the postulated consensus sequence for Grb2 SH2 recognition. Following treatment with IL-3 or GM-CSF, but not IL-4, SHPTP2 co-immunoprecipitated with antibodies directed against the p85 subunit of PI 3'-kinase. This was partially blocked by the same phosphopeptides that blocked Grb2-SH2 binding to SHPTP2. Importantly, treatment with IL-3 resulted in a 2-3-fold increase in SHPTP2 phosphatase activity. These results suggest that SHPTP2 may play an important role in integrating signals from the IL-3 and GM-CSF receptors to both Ras and PI 3'-kinase.lld:pubmed
pubmed-article:7522233pubmed:languageenglld:pubmed
pubmed-article:7522233pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7522233pubmed:citationSubsetIMlld:pubmed
pubmed-article:7522233pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7522233pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7522233pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7522233pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7522233pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7522233pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7522233pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7522233pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7522233pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7522233pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7522233pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7522233pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7522233pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7522233pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7522233pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7522233pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7522233pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7522233pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7522233pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7522233pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7522233pubmed:statusMEDLINElld:pubmed
pubmed-article:7522233pubmed:monthSeplld:pubmed
pubmed-article:7522233pubmed:issn0021-9258lld:pubmed
pubmed-article:7522233pubmed:authorpubmed-author:SchraderJ WJWlld:pubmed
pubmed-article:7522233pubmed:authorpubmed-author:WelhamM JMJlld:pubmed
pubmed-article:7522233pubmed:authorpubmed-author:LeslieK BKBlld:pubmed
pubmed-article:7522233pubmed:authorpubmed-author:JirikFFlld:pubmed
pubmed-article:7522233pubmed:authorpubmed-author:DechertUUlld:pubmed
pubmed-article:7522233pubmed:issnTypePrintlld:pubmed
pubmed-article:7522233pubmed:day23lld:pubmed
pubmed-article:7522233pubmed:volume269lld:pubmed
pubmed-article:7522233pubmed:ownerNLMlld:pubmed
pubmed-article:7522233pubmed:authorsCompleteYlld:pubmed
pubmed-article:7522233pubmed:pagination23764-8lld:pubmed
pubmed-article:7522233pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:7522233pubmed:meshHeadingpubmed-meshheading:7522233-...lld:pubmed
pubmed-article:7522233pubmed:meshHeadingpubmed-meshheading:7522233-...lld:pubmed
pubmed-article:7522233pubmed:meshHeadingpubmed-meshheading:7522233-...lld:pubmed
pubmed-article:7522233pubmed:meshHeadingpubmed-meshheading:7522233-...lld:pubmed
pubmed-article:7522233pubmed:meshHeadingpubmed-meshheading:7522233-...lld:pubmed
pubmed-article:7522233pubmed:meshHeadingpubmed-meshheading:7522233-...lld:pubmed
pubmed-article:7522233pubmed:meshHeadingpubmed-meshheading:7522233-...lld:pubmed
pubmed-article:7522233pubmed:meshHeadingpubmed-meshheading:7522233-...lld:pubmed
pubmed-article:7522233pubmed:meshHeadingpubmed-meshheading:7522233-...lld:pubmed
pubmed-article:7522233pubmed:meshHeadingpubmed-meshheading:7522233-...lld:pubmed
pubmed-article:7522233pubmed:meshHeadingpubmed-meshheading:7522233-...lld:pubmed
pubmed-article:7522233pubmed:meshHeadingpubmed-meshheading:7522233-...lld:pubmed
pubmed-article:7522233pubmed:meshHeadingpubmed-meshheading:7522233-...lld:pubmed
pubmed-article:7522233pubmed:meshHeadingpubmed-meshheading:7522233-...lld:pubmed
pubmed-article:7522233pubmed:meshHeadingpubmed-meshheading:7522233-...lld:pubmed
pubmed-article:7522233pubmed:meshHeadingpubmed-meshheading:7522233-...lld:pubmed
pubmed-article:7522233pubmed:meshHeadingpubmed-meshheading:7522233-...lld:pubmed
pubmed-article:7522233pubmed:meshHeadingpubmed-meshheading:7522233-...lld:pubmed
pubmed-article:7522233pubmed:meshHeadingpubmed-meshheading:7522233-...lld:pubmed
pubmed-article:7522233pubmed:meshHeadingpubmed-meshheading:7522233-...lld:pubmed
pubmed-article:7522233pubmed:meshHeadingpubmed-meshheading:7522233-...lld:pubmed
pubmed-article:7522233pubmed:meshHeadingpubmed-meshheading:7522233-...lld:pubmed
pubmed-article:7522233pubmed:meshHeadingpubmed-meshheading:7522233-...lld:pubmed
pubmed-article:7522233pubmed:year1994lld:pubmed
pubmed-article:7522233pubmed:articleTitleInterleukin (IL)-3 and granulocyte/macrophage colony-stimulating factor, but not IL-4, induce tyrosine phosphorylation, activation, and association of SHPTP2 with Grb2 and phosphatidylinositol 3'-kinase.lld:pubmed
pubmed-article:7522233pubmed:affiliationBiomedical Research Centre, University of British Columbia, Vancouver, Canada.lld:pubmed
pubmed-article:7522233pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7522233pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:7522233pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:5781entrezgene:pubmedpubmed-article:7522233lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7522233lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7522233lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7522233lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7522233lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7522233lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7522233lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7522233lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7522233lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7522233lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7522233lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7522233lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7522233lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7522233lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7522233lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7522233lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7522233lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7522233lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7522233lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7522233lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7522233lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7522233lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7522233lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7522233lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7522233lld:pubmed
More...